Single‐dose and steady‐state pharmacokinetics of clomipramine, yohimbine and clomipramine/yohimbine combination: A clinical drug–drug interaction study

Documenti analoghi

• A physiologically‐based pharmacokinetic precision dosing approach to manage dasatinib drug–drug interactions
  di: Christina Kovar, et al.
  Pubblicazione: (2024)
• Using pharmacokinetic tomography—Cutaneous pharmacokinetics of topical drugs (FDA)
  Pubblicazione: (2024)
• Physiologically based pharmacokinetic modeling of imatinib and N‐desmethyl imatinib for drug–drug interaction predictions
  di: Helena Leonie Hanae Loer, et al.
  Pubblicazione: (2024)
• Physiologically based pharmacokinetic modeling of drug–drug interactions between ritonavir‐boosted atazanavir and rifampicin in pregnancy
  di: Shakir Atoyebi, et al.
  Pubblicazione: (2024)
• Evaluation of the drug–drug interaction potential of brigatinib using a physiologically‐based pharmacokinetic modeling approach
  di: Michael J. Hanley, et al.
  Pubblicazione: (2024)